Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.
Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.
The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…
Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.
Two pioneering companies are poised to explore the genetic frontiers of probiotic bacteria, seeking out strains that can produce sustainable quantities of life-enhancing microbial metabolites.
A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.
Industry
Sponsored by
Novozymes and Chr. Hansen have successfully merged to form Novonesis, heralding a new chapter in sustainable business practices and environmental stewardship.
The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.
The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.
The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.
